Alterity Therapeutics Investor Relations Material

Alterity Therapeutics Limited is a biotechnology company focused on developing therapies for neurodegenerative diseases. The company specializes in small molecule treatments designed to target underlying biological processes associated with disorders such as Parkinsons and other neurological conditions. The company is headquartered in Melbourne, Australia, and its shares are listed on the ASX.